The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the alliance will be to double five-year survival for patients with lung cancer by 2025.

July 17, 2019 — Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study. 

A lot of computers are being made without disk readers, an indication that this form of media is on the way out. So why does the medical community continue to rely on CDs to transfer images?

July 16, 2019 — Computational pathology company Paige announced the publication of an article in Nature Medicine describing an artificial intelligence (AI) system for computational pathology that achieves clinical-grade accuracy levels.

Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to quickly send 3-D DICOM volumetric data to colleagues for one-click review. The updated version provides a U.S. Food and Drug Administration (FDA)-approved 3-D DICOM web viewer with new tools such as measurements, the ability to discuss cases with messaging, viewing of mesh file types such as STL and more.

ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting, July 14-18 in San Antonio, Texas.

NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-99) processing facility in Beloit, Wis., with equipment installation currently underway. Establishing this processing facility is part of NorthStar’s staged development and dual processing pathway approach to expanding current capacity and efficiencies in Mo-99 production.

RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources. RayCare is being continually developed in collaboration with some of the leading cancer centers worldwide, according to RaySearch.

Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)] and shallow [Hp(0.07)] measurements of both photon and beta radiation.

Example of an intentionally truncated CT image
Example calculation from truncated images.

One of the main benefits of a radiation dose management system is the possibility to automatically generate alerts when the dose exceeds certain thresholds. These dose thresholds are mainly based on national Diagnostic Reference Levels (DRLs), which are defined for a standard-sized patient. An advanced dose management system offers the possibility to automatically select the group of patients by defining a patient size range in terms of weight, effective diameter or Water Equivalent Diameter (WED). As weight is not always filled in, WED, an attenuation-based metric, has become the favourite parameter to indicate patient size. But how accurately is WED calculated? Are we sure that our group of standard-sized patients does not include patients with wrong size calculation? Especially when everything happens automatically, how can we know that a high dose alert does not indicate a bigger patient for whom the size was not correctly calculated?
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now